An Online Survey of Patients' Experiences Since the Rescheduling of Hydrocodone: The First 100 Days

Pain Medicine : the Official Journal of the American Academy of Pain Medicine
Jan ChambersSteven D Passik

Abstract

To conduct an Internet patient survey through the National Fibromyalgia & Chronic Pain Association on reactions to the first 100 days following the rescheduling of hydrocodone. Face-valid survey questions were created with expert consensus along with repurposed questions used on previous NFMCPA surveys covering domains such as demographics and symptoms. The questionnaire was designed to be administered over the Internet. 6,420 responders met screening criteria and completed the survey. Most (5,181, or 82.5%) had been prescribed hydrocodone for more than 1 year. 2,296, (39.0%) reported no changes in access to hydrocodone, while the majority experienced some barriers. Of those who could no longer get hydrocodone, 1,067 (18.1%) borrowed pain medications, 1,007 (17.1%) turned to marijuana, 773 (13.1%) used alcohol, and 135 (2.3%) used illicit drugs. Most respondents had to visit their healthcare providers more often (N = 3,699, 64.2%) and 1,735 (30.3%) reported some type of issue interacting with their pharmacy. Most felt that the rescheduling was neither a fair nor appropriate solution to the abuse of hydrocodone (N = 4,938, 88.3%). For those still working, 801 (46.2%) reported that they had missed work because of the stricter reg...Continue Reading

References

Feb 27, 2007·Journal of Opioid Management·Steven D PassikKenneth L Kirsh
Feb 10, 2011·International Journal of Rheumatic Diseases·Gene-Siew NgianGeoffrey O Littlejohn
Oct 4, 2011·The American Journal of Medicine·Mary-Ann FitzcharlesYoram Shir
Jul 5, 2012·Der Schmerz·C SommerUNKNOWN Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften
Feb 1, 2013·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Jacob T Painter, Leslie J Crofford
Feb 2, 2013·Current Rheumatology Reports·Daniel KrashinJane Ballantyne
Mar 15, 2013·Clinical Therapeutics·Jacob T PainterJeffery Talbert
Apr 12, 2013·Pain Research and Treatment·Mary-Ann FitzcharlesYoram Shir
Dec 7, 2013·Regional Anesthesia and Pain Medicine·Ronald A WassermanAfton L Hassett
Feb 1, 2014·The Clinical Journal of Pain·Xiaomei PengDanette Hann
Dec 23, 2014·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Lesley M ArnoldAndrew Clair
Mar 11, 2015·The Clinical Journal of Pain·Charles E ArgoffLynne Pauer

❮ Previous
Next ❯

Citations

Jan 28, 2016·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Kelley CarrollAngela Stotts
Nov 17, 2015·PM & R : the Journal of Injury, Function, and Rehabilitation·Lynn R Webster, Martin Grabois
Nov 30, 2016·Journal of Gerontological Nursing·Barbara St Marie, Paul Arnstein
Apr 13, 2017·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Mark Edmund Rose
Jun 27, 2017·Journal of Gerontological Nursing·Paul ArnsteinHoward K Butcher
Sep 7, 2018·Pharmacoepidemiology and Drug Safety·Irene B MurimiG Caleb Alexander
Mar 16, 2019·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Taylor J StecklerBrian C Lund
Mar 14, 2020·JMIR Research Protocols·Jacqui McCoyRaimondo Bruno
Jan 22, 2021·The International Journal on Drug Policy·Jonathan P CaulkinsMichael Rath
Nov 1, 2020·Journal of the American Pharmacists Association : JAPhA·Silken A UsmaniScott Martin Vouri
Oct 11, 2021·Current Pain and Headache Reports·Robert A DuarteLawrence F Kobak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of the Arkansas Medical Society
David Wroten
The Medical Letter on Drugs and Therapeutics
JAMA : the Journal of the American Medical Association
M D Wilson, A Joffe
© 2021 Meta ULC. All rights reserved